Multiple human papilloma virus infections predominant in squamous cell cervical carcinoma in Bandung
Main Article Content
Abstract
Article Details
Issue
Section
The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.
How to Cite
References
Castellsagué X. Natural history and
epidemiology of HPV infection and cervical
cancer. Gynecol Oncol 2008;110 Suppl 2:S4-7.
Aziz MF. Gynecological cancer in Indonesia.
Gynecol Oncol 2009;20:8-10.
Khenchouche A, Sadouki N, Boudriche A,
Houali K, Graba A, Ooka T, et al. Human
papillomavirus and Epstein-Barr virus coinfection
in cervical carcinoma in Algerian
women. Virol J 2013;10:340. doi:10.1186/1743-
X-10-340.
Bruni L, Diaz M, Castellsague X, Ferrer E,
Bosch FX, de Sanjosé S. Cervical human
papillomavirus prevalence in 5 continents: metaanalysis
of 1 million women with normal
cytological findings. J Infect Dis 2010;202:1789-
de Sanjose S, Quint WG, Alemany L, Geraets
DT, Klaustermeier JE, Lloveras B for
Retrospective International Survey and HPV
Time Trends Study Group. Human
papillomavirus genotype attribution in invasive
cervical cancer: a retrospective cross-sectional
worldwide study. Lancet Oncol 2010;11:1048-
de Sanjosé S, Diaz M, Castellsagué X, Clifford
G, Bruni L, Munoz N. Worldwide prevalence and
genotype distribution of cervical human
papillomavirus DNA in women with normal
cytology: a meta-analysis. Lancet Infect Dis
;7:453-9.
Sjoeborg KD, Tropé A, Lie AK, Jonassen CM,
Steinbakk M, Hansen M. HPV genotype
distribution according to severity of cervical
neoplasia. Gynecol Oncol 2010;118:29-34.
Coutlée F, Ratnam S, Ramanakumar AV, Insinga
RR, Bentley J, Escott N, et al. Distribution of
human papillomavirus genotypes in cervical
intraepithelial neoplasia and invasive cervical
cancer in Canada. J Med Virol 2011;83:1034-
de Boer MA, Vet JN, Aziz MF, Cornain S,
Purwoto G, van den Akker BE, et al. Human
papillomavirus type 18 and other risk factors for
cervical cancer in Jakarta, Indonesia. Int J
Gynecol Cancer 2006;16:1809-14.
Vet JN, de Boer MA, van den Akker BE, Siregar
B, Lisnawati, Budiningsih S, et al. Prevalence
of human papillomavirus in Indonesia: a
population-based study in three regions. Br J
Cancer 2008;99:214-8.
Lax S. Histophatology of cervical precursor
lesions and cancer. Acta Dermatovenerol Alp
Panonica Adriat 2011;20:125-33.
Schiller JT, Day PM, Kines RC. Current
understanding of the mechanism of HPV
infection. Gynecol Oncol 2010;118 Suppl: S12-
Stanley M. HPV-immune response to infection
and vaccination. Infect Agent Cancer 2010;5:19.
doi:10.1186/1750-9378-5-19.
Munoz N, Bosch FX, de Sanjose S, Herrero
R, Castellsague X, Shah KV, et al. Epidemiologic
classification of human papillomavirus types
associated with cervical cancer. N Engl J Med
;348:518-27.
Schellekens MC, Dijkman A, Aziz MF, Siregar
B, Cornain S, Kolkman-Uljee S, et al. Prevalence
of single and multiple HPV types in cervical
carcinomas in Jakarta, Indonesia. Gynecol Oncol
;93:49-53.
Wong FKY, Ching JCY, Chow JKF. Comparison
of the DiagCor GenoFlow human papillomavirus
array test and Roche linear array HPV
genotyping test. Open Virol J 2010;4:169–74.
Panigoro R, Susanto H, Novel SS, Hartini S,
Sahiratmadja E. HPV genotyping linear assay
test comparison in cervical cancer patients:
implications for HPV prevalence and molecular
epidemiology in a limited-resource area in
Bandung, Indonesia. Asian Pac J Cancer Prev
;14:5843-7.
Dona MG, Benevolo M, Pimpinelli F, Battista
M, Rollo F, Stivali F. Comparative evaluation of
different DNA extraction methods for
HPV genotyping by linear array and INNOLiPA.
J Med Virol 2011;83:1042-7.
Domingo EJ, Noviani R, Noor MR, Ngelangel
CA, Limpaphayom KK, Thuan TV, et al.
Epidemiology and prevention of cervical cancer
in Indonesia, Malaysia, the Philippines, Thailand
and Vietnam. Vaccine 2008;26 Suppl 12:M71-